TAG:
ameripath
Specialty Laboratories, IMPATH, Roche, Abbott Laboratories, Celera Diagnostics
By Robert Michel | From the Volume X No. 6 – May 5, 2003 Issue
SPECIALTY LABORATORIES RESTORING STABILITY IN SPECIMEN VOLUME IT’S NO SURPRISE THAT COMPETITORS of Specialty Laboratories, Inc. have been willing to spread a variety of rumors about the laboratory company, given its well-publicized troubles with government regulators last …
Buyout of AmeriPath Riles Some Shareholders
By Robert Michel | From the Volume X No. 3 – March 3, 2003 Issue
CEO SUMMARY: Owners of the few remaining independent private laboratory companies closely watch prices paid by lab buyers. In the pending sale of AmeriPath to private equity investor Welsh, Carson, Anderson, & Stowe, dissenting shareholders disclosed several aspects of the valuation p…
“Where’s The Beef?” AP’s AWOL at AmeriPath
By Robert Michel | From the Volume X No. 3 – March 3, 2003 Issue
REMEMBER THAT FAMOUS TELEVISION commercial from Wendy’s burger restaurants? The elderly lady scrutinizes a big hamburger bun that’s obviously short on meat and asks the seminal question “Where’s the beef?” In 1984, it was a catch line that captured the American imagination and was repeated…
The Lab Industry’s Market Share Juggernauts
By R. Lewis Dark | From the Volume X No. 2 – February 10, 2003 Issue
MOST OF YOU KNOW THAT 2002 WAS AN UNEXPECTEDLY ACTIVE YEAR for public laboratory company acquisitions. The entire rank of mid-market public laboratory companies actively selling routine testing services to physicians’ offices was swept from the board by Quest Diagnostics Incorporated and L…
LabCorp Starts Tinkering With DIANON Systems
By Robert Michel | From the Volume X No. 2 – February 10, 2003 Issue
CEO SUMMARY: For almost two decades, DIANON Systems supported one of the most successful sales and marketing programs in the public laboratory sector. However, despite its pre-acquisition statements that it would retain DIANON’s operational integrity, LabCorp has already begun to implem…
Quest Ready to Move on Unilab, Announces Its 2002 Earnings
By Robert Michel | From the Volume X No. 2 – February 10, 2003 Issue
PERSISTENCE IS ABOUT TO PAY OFF for Quest Diagnostics Incorporated. After ten months of effort, it expects to finalize its acquisition of Unilab Corporation within weeks. But the Unilab acquisition soon to close looks different than the acquisition that was original…
“January 20, 2003 Intelligence: Late Breaking Lab News”
By Robert Michel | From the Volume X No. 1 – January 20, 2003 Issue
December proved to be an eventful month for many companies in the lab industry. Here’s some key items of interest, many to be followed in more detail in coming issues of THE DARK REPORT: •AmeriPath, Inc. is to be sold to Welsh, Carson, Anderson & Stowe, a privat…
“December 9, 2002 Intelligence: Late Breaking Lab News”
By Robert Michel | From the Volume IX No. 17 – December 9, 2002 Issue
This morning AmeriPath, Inc. announced that it would be purchased by Welsh Carson Anderson & Stowe, a private equity firm based in New York City. Welsh Carson will pay $21.25 per share, a 30% premium over AmeriPath’s closing NASDAQ price of $16.45 on Friday, Decemb…
More Consolidation: Where Will It Lead?
By R. Lewis Dark | From the Volume IX No. 16 – November 18, 2002 Issue
I CERTAINLY DID NOT FORESEE ALL THE LAB ACQUISITION ACTIVITY that occurred during 2002. Compared to recent years, both Quest Diagnostics Incorporated and Laboratory Corporation of America have been on a buying spree this year. Quest Diagnostics acquired Amer…
Why DIANON Sale Alters Anatomic Path Market
By Robert Michel | From the Volume IX No. 16 – November 18, 2002 Issue
CEO SUMMARY: By acquiring DIANON Systems, LabCorp raises the level of competition for tissue specimens originating in physicians’ offices. LabCorp’s acquisition is also a validation of predictions that cancer diagnostics will be a high-growth segment of laboratory medicine. Anatomic p…
CURRENT ISSUE

Volume XXXII, No. 6 – April 21, 2025
Now that a federal judge has vacated the FDA’s LDT rule, The Dark Report analyzes the judgement and notes the various steps the FDA could take in response. Also, lab testing at pharmacies is proving to be less successful than was once anticipated.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.
Topics
- Anatomic Pathology
- Clinical Chemistry
- Clinical Laboratory
- Clinical Laboratory Trends
- Digital Pathology
- Genetic Testing
- In Vitro Diagnostics
- IVD/Lab Informatics
- Lab Intelligence
- Lab Marketplace
- Lab Risk & Compliance
- Laboratory Automation
- Laboratory Billing
- Laboratory Compliance
- Laboratory Equipment
- Laboratory Information Systems
- Laboratory Management
- Lean Six Sigma
- Managed Care Contracts
- Molecular Diagnostics
- Pathology Trends
- People
- Uncategorized